ClinicalTrials.govpublic full text
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
solid tumors, shp2, ptpn11, nsclc, egfr, kras g12, braf class 3, nf1 lof, advanced solid tumor, advanced solid malignancies, melanoma, skin cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 906675
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.